Literature DB >> 19002973

Advances in animal cell recombinant protein production: GS-NS0 expression system.

L M Barnes1, C M Bentley, A J Dickson.   

Abstract

The production of recombinant proteins using mammalian cell expression systems is of growing importance within biotechnology, largely due to the ability of specific mammalian cells to carry out post-translational modifications of the correct fidelity. The Glutamine Synthetase-NS0 system is now one such industrially important expression system.Glutamine synthetase catalyses the formation ofglutamine from glutamate and ammonia. NS0 cellscontain extremely low levels of endogenous glutaminesynthetase activity, therefore exogenous glutaminesynthetase can be used efficiently as a selectablemarker to identify successful transfectants in theabsence of glutamine in the media. In addition, theinclusion of methionine sulphoximine, an inhibitor ofglutamine synthetase activity, enables furtherselection of those clones producing relatively highlevels of transfected glutamine synthetase and henceany heterologous gene which is coupled to it. Theglutamine synthetase system technology has been usedfor research and development purposes during thisdecade and its importance is clearly demonstrated nowthat two therapeutic products produced using thissystem have reached the market place.

Entities:  

Year:  2000        PMID: 19002973      PMCID: PMC3449689          DOI: 10.1023/A:1008170710003

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  149 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Effects of the position of the simian virus 40 enhancer on expression of multiple transcription units in a single plasmid.

Authors:  T Kadesch; P Berg
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

3.  Variations in the heavy polypeptide chain structure of gamma myeloma immunoglobulins from an inbred strain of mice and a hypothesis as to their origin.

Authors:  M Potter; E Appella; S Geisser
Journal:  J Mol Biol       Date:  1965-12       Impact factor: 5.469

4.  Studies on the mechanism of inhibition of glutamine synthetase by methionine sulfoximine.

Authors:  R A Ronzio; W B Rowe; A Meister
Journal:  Biochemistry       Date:  1969-03       Impact factor: 3.162

5.  Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.

Authors:  G Köhler; S C Howe; C Milstein
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

6.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

Authors:  L J Reitzer; B M Wice; D Kennell
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

7.  Studies on the inhibition of glutamine synthetase by methionine sulfone.

Authors:  W B Rowe; A Meister
Journal:  Biochemistry       Date:  1973-04-10       Impact factor: 3.162

8.  Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells.

Authors:  R J Kaufman; L C Wasley; A J Spiliotes; S D Gossels; S A Latt; G R Larsen; R M Kay
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

9.  Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.

Authors:  G Köhler; C Milstein
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

10.  Use of a murine T-cell hybridoma expressing human T-cell receptor alpha- and beta-gene products as a tool for the production of human T-cell receptor-specific monoclonal antibodies.

Authors:  A Zumla; A McCormack; A George; R Batchelor; R Lechler
Journal:  Hum Immunol       Date:  1992-11       Impact factor: 2.850

View more
  20 in total

1.  Using cell engineering and omic tools for the improvement of cell culture processes.

Authors:  Darrin Kuystermans; Britta Krampe; Halina Swiderek; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2007-02-24       Impact factor: 2.058

2.  On-chip microelectrode impedance analysis of mammalian cell viability during biomanufacturing.

Authors:  Rachita Sharma; Tobias Blackburn; Weiwei Hu; Kelly Wiltberger; Orlin D Velev
Journal:  Biomicrofluidics       Date:  2014-09-11       Impact factor: 2.800

3.  The enhancement of antibody concentration and achievement of high cell density CHO cell cultivation by adding nucleoside.

Authors:  Yasuhiro Takagi; Takuya Kikuchi; Ryuta Wada; Takeshi Omasa
Journal:  Cytotechnology       Date:  2017-03-02       Impact factor: 2.058

Review 4.  Recent advances in mammalian protein production.

Authors:  Ashok D Bandaranayake; Steven C Almo
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

5.  Towards the molecular characterization of the stable producer phenotype of recombinant antibody-producing NS0 myeloma cells.

Authors:  Y Prieto; L Rojas; L Hinojosa; I González; D Aguiar; K de la Luz; A Castillo; R Pérez
Journal:  Cytotechnology       Date:  2011-03-20       Impact factor: 2.058

6.  Mammalian Cell Culture as a Platform for Veterinary Vaccines.

Authors:  Thailín Lao González; Ileanet Ávalos Olivera; Alina Rodríguez-Mallon
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Protein production from the structural genomics perspective: achievements and future needs.

Authors:  Steven C Almo; Scott J Garforth; Brandan S Hillerich; James D Love; Ronald D Seidel; Stephen K Burley
Journal:  Curr Opin Struct Biol       Date:  2013-05-01       Impact factor: 6.809

8.  Automation of cell line development.

Authors:  Kristina Lindgren; Andréa Salmén; Mats Lundgren; Lovisa Bylund; Asa Ebler; Eric Fäldt; Lina Sörvik; Christel Fenge; Ulrica Skoging-Nyberg
Journal:  Cytotechnology       Date:  2009-03-21       Impact factor: 2.058

9.  Development of Animal-free, Protein-Free and Chemically-Defined Media for NS0 Cell Culture.

Authors:  Jinyou Zhang; David Robinson
Journal:  Cytotechnology       Date:  2005-06       Impact factor: 2.058

Review 10.  Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1β monoclonal antibody.

Authors:  Abhijit Chakraborty; Stacey Tannenbaum; Christiane Rordorf; Philip J Lowe; David Floch; Hermann Gram; Sandip Roy
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.